Skip to main content
Log in

Protective effect of magnesium supplementation on experimental 3-methyl cholantrene-induced fibrosarcoma and changes in tissue magnesium distribution during carcinogenesis in rats

  • Original Articles
  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

In this study, we wanted to examine the effect of magnesium (Mg2+) supplementation on the experimental 3-methyl cholantrene (3-MC)-induced fibrosarcoma and alterations in (Mg2+) distribution in several tissues of the rats, during carcinogenesis. It was determined that serum and tissue (Mg2+) levels of the rats in (Mg2+)-supplemented diet group were higher than those of the rats in the (Mg2+)-nonsupplemented and control groups. The mean time of fibrosarcoma development for (Mg2+)-supplemented group was longer than (Mg2+)-nonsupplemented group (p<0.05). Symptoms of hypermagnesemia were not observed in any of the rats. These results suggests that dietary (Mg2+) supplementation may have a partial anticarcinogenic effect on experimental 3-MC-induced fibrosarcoma by prolongation of the latent period of carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. B. M. Altura, Importance of magnesium measurements in clinical medicine and therapeutics: Introduction to workshop and symposium,Magnesium Trace Element 10, 5–9 (1991).

    Google Scholar 

  2. B. M. Altura, Basic biochemistry and physiology of magnesium: A brief review,Magnesium, Trace Element 10, 167–171 (1991).

    CAS  Google Scholar 

  3. M. Bara, A. G. Bara, and J. Durlach, Magnesium and electrical properties of membranes, inMagnesium in Cellular Processes and Medicine, B. M. Altuna, J. Durlach, and M. S. Seeling (eds.), Karger, Basel, pp 106–120 (1987).

    Google Scholar 

  4. J. Durlach, M. Bara, A. G. Bara, et al., Relationship between magnesium cancer and carcinogenic or anticancer metals,Anticancer Res. 6, 1353–1362 (1986).

    PubMed  CAS  Google Scholar 

  5. G. M. Hass, R. M. Galt, and G. H. Laing, Induction of rat T cell lymphoma-leukemia by magnesium deficiency-A study of fetal defense against maternal neoplasia,Magnesium 8, 45–55 (1989).

    PubMed  CAS  Google Scholar 

  6. P. A. McCreary, H. A. Battifora, and B. M. Hahneman, Leukocytosis, bone marrow hyperplasia and leukemia in choronic magnesium deficiency in the rat,Blood 29, 683–690 (1967).

    PubMed  CAS  Google Scholar 

  7. R. Gossrau, J. Vormann, and T. Günther, Enzyme histochemistry of malignant T cell lymphoma due to chronic magnesium deficiency in rats,Histochemistry 80, 183–186 (1984).

    Article  PubMed  CAS  Google Scholar 

  8. B. J. Mills, W. L. Broghamer, P. J. Higgins, et al., Inhibition of tumor growth by magnesium depletion of rats,J. Nutr. 114, 739–745 (1984).

    PubMed  CAS  Google Scholar 

  9. G. A. Young and F. M. Parsons, The effects of dietary deficiencies of magnesium and potassium on the growth and chemistry of transplanted tumours and host tissues in the rat,Eur. J. Cancer 13, 103–113 (1977).

    PubMed  CAS  Google Scholar 

  10. V. Digiesi, R. Bandinelli, P. Bisceglie, et al., Magnesium in tumoral tissues, in the muscle and serum of subjects suffering from neoplasia,Biochem. Med. 29, 360–363 (1983).

    Article  PubMed  CAS  Google Scholar 

  11. T. Durlach, Summary of three recent magnesium meetings,Magnesium 6, 274–280 (1987).

    Google Scholar 

  12. Z. Szmeja and H. Konezewska, Der Magnesiumgehalt bei larynxpråkanzerosen und larynxkarzinomen,HNO 34, 85–87 (1986).

    PubMed  CAS  Google Scholar 

  13. S. L. Rizk and H. H. Sky-Peck, Comparison between concentrations of trace elements in normal and neoplastic human breast tissue,Cancer Res. 44, 5390–5394 (1984).

    PubMed  CAS  Google Scholar 

  14. J. K. Brennan, A. Lichtman, J. K. Chamberlain, and P. Leblond, Isolation of variant lymphoma cells with reduced growth requirements for extracellular calcium and magnesium and enhanced oncogenicit,Blood 47, 447–459 (1976).

    PubMed  CAS  Google Scholar 

  15. J. T. Bradbury, W. E. Bachmann, and M. G. Lewisohn, The production of cancer by some new chemical compound,Cancer Res. 10, 685–694 (1941).

    Google Scholar 

  16. P. Bois, E. B. Sandborn, and P. E. Messier, A study of thymic lymphosarcoma developing in magnesium-deficient rats,Cancer Res. 29, 763–775 (1969).

    PubMed  CAS  Google Scholar 

  17. L. A. Poirier, K. S. Kasprzak, K. L. Hoover, et al., Effects of calcium and magnesium acetates on the carcinogenecity of cadmium choloride in wistar rats,Cancer Res. 43, 4575–4581 (1983).

    PubMed  CAS  Google Scholar 

  18. L. A. Poirier, J. C. Theiss, L. J. Arnold, et al., Inhibition by magnesium and calcium acetates of lead subacetate and nickel acetate induced lung tumors in strain a mice,Cancer Res. 44, 1520–1522 (1984).

    PubMed  CAS  Google Scholar 

  19. A. W. Horton and B. T. Denial, Carcinogenesis of the skin. A new examination of methods for quantitive measurement of the potencies of complex material,Cancer Res. 15, 701–709 (1956).

    Google Scholar 

  20. M. Diez, M. Arroyo, F. J. Cerdan, et al., Serum and tissue metal levels in lung cancer,Oncology 46, 230–234 (1989).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patiroğlu, T., Şahin, G., Kontaş, O. et al. Protective effect of magnesium supplementation on experimental 3-methyl cholantrene-induced fibrosarcoma and changes in tissue magnesium distribution during carcinogenesis in rats. Biol Trace Elem Res 56, 179–185 (1997). https://doi.org/10.1007/BF02785391

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02785391

Index Entries

Navigation